Neutralization of the bioactivity of GM-CSF by auto-antibodies causes another auto-immune disease, idiopathic pulmonary alveolar proteinosis [6] and GM-CSF is used to treat this condition [7], [8]. The gene discussed is CSF2; the disease is autoimmune pulmonary alveolar proteinosis.